News

First Pill for Postpartum Depression Shows Varied Real-World Results
Some women’s symptoms improved quickly after taking the pill, but depression persisted in others. Doctors are trying to learn ...
Sanitariums and Stigma: When TB Was Common in the U.S.
After The Times published an interview with John Green about his new book on tuberculosis, many readers wrote to share their ...
Clinical Pain Advisor23h
Sublingual Cyclobenzaprine Shows Broad Symptom Relief in Fibromyalgia Phase 3 Trial
Bedtime TNX-102 SL was safe and effective for the treatment of fibromyalgia by improving symptoms of pain, disrupted sleep, and fatigue.
Healio3d
Neutrophil modulator may meet ‘urgent need’ for safer, more effective UC treatment
An oral neutrophil modulator appeared safe and demonstrated signals of efficacy in patients with moderate to severe ...
Infectious Disease Advisor1d
Prolonged Antibiotic Therapy Common for Gram-Negative BSIs Across US Hospitals
The duration of antibiotic therapy for GN-BSIs varied across US hospitals and was commonly longer than 10 days, including in patients with uncomplicated bacteremia.
Healio2d
Specialists debate systemic vs. local treatment of uveitic macular edema
Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.
Mediafeed on MSN2d
NAD+, NMN & NR: How these longevity supplements compare
NR: Most studies use 250–500 mg per day. This range has been shown to safely raise NAD+ levels in humans. NMN: Common doses ...